BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21148720)

  • 1. Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury.
    Spragg RG; Taut FJ; Lewis JF; Schenk P; Ruppert C; Dean N; Krell K; Karabinis A; Günther A
    Am J Respir Crit Care Med; 2011 Apr; 183(8):1055-61. PubMed ID: 21148720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome.
    Spragg RG; Lewis JF; Walmrath HD; Johannigman J; Bellingan G; Laterre PF; Witte MC; Richards GA; Rippin G; Rathgeb F; Häfner D; Taut FJ; Seeger W
    N Engl J Med; 2004 Aug; 351(9):884-92. PubMed ID: 15329426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dry powder aerosolization of a recombinant surfactant protein-C-based surfactant for inhalative treatment of the acutely inflamed lung.
    Ruppert C; Kuchenbuch T; Boensch M; Schmidt S; Mathes U; Hillebrand V; Henneke I; Markart P; Reiss I; Schermuly RT; Seeger W; Günther A
    Crit Care Med; 2010 Jul; 38(7):1584-91. PubMed ID: 20400897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratracheal application of recombinant surfactant protein-C surfactant to rabbits attenuates acute lung injury induced by intratracheal acidified infant formula.
    Mikawa K; Nishina K; Takao Y; Obara H
    Anesth Analg; 2004 May; 98(5):1273-9, table of contents. PubMed ID: 15105199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric calfactant in acute respiratory distress syndrome trial.
    Willson DF; Thomas NJ; Tamburro R; Truemper E; Truwit J; Conaway M; Traul C; Egan EE;
    Pediatr Crit Care Med; 2013 Sep; 14(7):657-65. PubMed ID: 23846250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome.
    Kesecioglu J; Beale R; Stewart TE; Findlay GP; Rouby JJ; Holzapfel L; Bruins P; Steenken EJ; Jeppesen OK; Lachmann B
    Am J Respir Crit Care Med; 2009 Nov; 180(10):989-94. PubMed ID: 19713451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant.
    Spragg RG; Lewis JF; Wurst W; Häfner D; Baughman RP; Wewers MD; Marsh JJ
    Am J Respir Crit Care Med; 2003 Jun; 167(11):1562-6. PubMed ID: 12649125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Farewell to exogenous surfactant therapy in acute lung injury/acute respiratory distress syndrome! Or, must we start all over again?
    Kesecioglu J
    Crit Care Med; 2010 Jul; 38(7):1606-7. PubMed ID: 20562549
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome.
    Häfner D; Germann PG; Hauschke D
    Br J Pharmacol; 1998 Jul; 124(6):1083-90. PubMed ID: 9720777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effects of phosphodiesterase-4 inhibition on effects of rSP-C surfactant.
    Häfner D; Germann PG
    Am J Respir Crit Care Med; 2000 May; 161(5):1495-500. PubMed ID: 10806144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive end-expiratory pressure modifies response to recombinant and natural exogenous surfactant in ventilated immature newborn rabbits.
    Hilgendorff A; Reiss I; Ruppert C; Hanfstingl T; Seliger AS; Gunther A; Ebsen M; Gortner L
    Biol Neonate; 2006; 90(3):210-6. PubMed ID: 16763385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early use of noninvasive positive pressure ventilation for acute lung injury: a multicenter randomized controlled trial.
    Zhan Q; Sun B; Liang L; Yan X; Zhang L; Yang J; Wang L; Ma Z; Shi L; Wei L; Li G; Yang L; Shi Z; Chen Y; Xu Q; Li W; Zhu X; Wang Z; Sun Y; Zhuo J; Liu Y; Li X; Wang C
    Crit Care Med; 2012 Feb; 40(2):455-60. PubMed ID: 22020236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratracheally applied rSP-C surfactant exhibits no anaphylactic shock reactions in a guinea pig model of acute lung hypersensitivity.
    Germann PG; Kemkowski J; Hauschke D; Steinhilber W; Häfner D
    Exp Toxicol Pathol; 1999 Nov; 51(6):495-505. PubMed ID: 10661808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of rSP-C surfactant on oxygenation and histology in a rat-lung-lavage model of acute lung injury.
    Häfner D; Germann PG; Hauschke D
    Am J Respir Crit Care Med; 1998 Jul; 158(1):270-8. PubMed ID: 9655740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of early treatment with rSP-C surfactant on oxygenation and histology in rats with acute lung injury.
    Häfner D; Germann PG; Hauschke D; Kilian U
    Pulm Pharmacol Ther; 1999; 12(3):193-201. PubMed ID: 10419839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchoscopic surfactant administration preserves gas exchange and pulmonary compliance after single lung transplantation in dogs.
    Friedrich I; Börgermann J; Splittgerber FH; Brinkmann M; Reidemeister JC; Silber RE; Seeger W; Schmidt R; Günther A
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):335-43. PubMed ID: 14762340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic and natural surfactant differentially modulate inflammation after meconium aspiration.
    Hilgendorff A; Rawer D; Doerner M; Tutdibi E; Ebsen M; Schmidt R; Guenther A; Gortner L; Reiss I
    Intensive Care Med; 2003 Dec; 29(12):2247-2254. PubMed ID: 12955179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inositol-trisphosphate reduces alveolar apoptosis and pulmonary edema in neonatal lung injury.
    Preuss S; Stadelmann S; Omam FD; Scheiermann J; Winoto-Morbach S; von Bismarck P; Knerlich-Lukoschus F; Lex D; Adam-Klages S; Wesch D; Held-Feindt J; Uhlig S; Schütze S; Krause MF
    Am J Respir Cell Mol Biol; 2012 Aug; 47(2):158-69. PubMed ID: 22403805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Provo multicenter early high-frequency oscillatory ventilation trial: improved pulmonary and clinical outcome in respiratory distress syndrome.
    Gerstmann DR; Minton SD; Stoddard RA; Meredith KS; Monaco F; Bertrand JM; Battisti O; Langhendries JP; Francois A; Clark RH
    Pediatrics; 1996 Dec; 98(6 Pt 1):1044-57. PubMed ID: 8951252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open lung ventilation preserves the response to delayed surfactant treatment in surfactant-deficient newborn piglets.
    van Veenendaal MB; van Kaam AH; Haitsma JJ; Lutter R; Lachmann B
    Crit Care Med; 2006 Nov; 34(11):2827-34. PubMed ID: 17006360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.